chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pm of the day receiving the pneumonia vaccine. Left upper arm swollen, hard and very warm to touch. Had limited movement. This lasted into the next day. Today, 12/15/2006, have a red flat rash area on the muscle of the upper left arm. The pain is lessening, but remains tender.
Sinus inflammation, aura migraine, double ear infection. Ringing in left ear two days after vaccine, ear infections diagnosed 8 days post shot. Augmentin and allergy pills prescribed..
I was given a flu vaccine at work on my left arm. The administering nurse gave it too high up on my shoulder. When she gave it she said "Oh I think I got it in your bone, you are just too skinny." She didn't pinch the muscle. I had pain for a few days and it kept getting worse and worse. I couldn't move my arm without pain. I got a steroid shot a few weeks later on 10/14/19.. It helped for about a week or two then I was seen by my work's wellness center on 10/30 and 11/6 and was referred to occupation medicine and physical therapy for bursitis/tendonitis/SIRVA (shoulder injury related to vaccine administration). I went to 7physical therapy sessions and have seen occupational therapy every 1-3 weeks since November. I am finally feeling better and am able to move my shoulder without pain.
pt recv vax 2DEC96 & 4 days post vax 7DEC96 pt died as a sudden infant death;It was also reported that skull x-ray done on 5DEC showed the pt was bradycephalic;poss mid inf coronal suture closure;
HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported. On 11-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Flu like symptoms; This case was reported by a consumer via patient support programs and described the occurrence of influenza-like symptoms in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient called and stated that he had flu like symptoms after the first dose six months ago. The patient was due for the second dose at the time of reporting.
1/27/21 injection site red and itching.  1/28/21 rash on arm, skin hot, fever, arm swollen and itchy.
Mom presented to office within 24 hrs post Pneumovax and Flu vaccine injections with c/o pain redness and slight swelling to Rt upper arm. Upon examination MD found fine morbelli form rash around pneumovax injection site with redness and tenderness. Pt tx with Claritan 10mg and Children's Tylenol. No acute distress noted.
her leg is swollen; can barely walk; like ankle is broken, can barely walk; she began experiencing discomfort on the joints on her arms and elbows; excruciating pain on feet and ankle; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle), PERIPHERAL SWELLING (her leg is swollen), GAIT DISTURBANCE (can barely walk) and ARTHRALGIA (like ankle is broken, can barely walk) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B214 and 007B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle) and ARTHRALGIA (like ankle is broken, can barely walk). On an unknown date, the patient experienced PERIPHERAL SWELLING (her leg is swollen) and GAIT DISTURBANCE (can barely walk). The patient was treated with OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle), PERIPHERAL SWELLING (her leg is swollen), GAIT DISTURBANCE (can barely walk) and ARTHRALGIA (like ankle is broken, can barely walk) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication are blood pressure medicine with very low dosage.   This case was linked to MOD-2021-230046 (Patient Link).
Syncopal episode occurred 2 minutes after immunization. Assited to supine position with legs elevated. B/P 84/60. HR 64. Oxygen saturation 98%. Cool cloth to forehead & neck. Lips pale, skin moist. C/O nausea & dizziness.  Recovered after 10 minutes. Denied further symptoms.
Guillain-Barre' Syndrome; Paralysis from waste down to include bowel and renal functions, loss of muscular control - complete paralysis from knees down; no muscular movement or nerve stimulation.  Neuropathy in feet, loss of muscular mass in legs. Nerve loss of stimulation and movement  upward to right arm and hand; resulting in loss of muscular strength in fingers of patient's dominate right hand.  Blood Pressure is not being controlled and maintained at a normal range with medication; continuing increasing Diastolic pressures with fluctuations. Heart Arrhythmia. Head aches. Visual changes in near ranges. Mood Swings and depression. Patient had onset of extreme pain and nerve stimulation radiating within upper abdominal and chest cavity.
5 minutes after receiving vaccine:  Itchy throat  Mouth numb Runny nose  30 minutes Eyes watering Headache
The needle was inserted high up on my left shoulder, which was quit painful.  When the vaccine was injected, it caused additional discomfort.  Within 30 minutes, the left shoulder joint became agonizingly pain with any movement and I had loss of mobility.  Several hours later, the pain continued to worsen and any movement of the arm caused debilitating sharp pain.    During the night I used ice packs and took Advil, however the problem continued to worsen.  Today I am very concerned that the vaccine may have caused an injury to my shoulder.
Patient was accidentally given 0.3 mL of normal saline instead of a mixed vaccine. She did not report any issues. She returned to the pharmacy for a mixed vaccine the next day.
2 blotchy (1-small, 1-large area), red rashes blanched, non tender, non indurated near injection site 72 hrs later.
Left axillary discomfort 24 hours after receiving vaccine. Patient seen in office 12/20/2021 for follow up visit.
caught COVID 2 weeks after getting last booster; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (caught COVID 2 weeks after getting last booster) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jul-2022, the patient experienced COVID-19 (caught COVID 2 weeks after getting last booster). At the time of the report, COVID-19 (caught COVID 2 weeks after getting last booster) outcome was unknown.            No concomitant medication information was provided.  The patient had received the 4th booster dose of Moderna vaccine.  The reporter was enquiring about when the patient would be eligible to receive the bivalent booster dose, was it after 90 days from the 4th booster dose or was it after 90 days from the COVID event.  No treatment information was provided.   Reporter did not allow further contact
She was feeling extremely tired and she hardly can keep her eyes open; Sleeping all day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 16May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset May2021, outcome "unknown", described as "She was feeling extremely tired and she hardly can keep her eyes open"; SOMNOLENCE (non-serious) with onset May2021, outcome "unknown", described as "Sleeping all day".  Additional information: The caller was calling about the Pfizer covid vaccine. The caller had her last vaccine on Sunday. Caller got the second dose of the Pfizer COVID-19 vaccine on Sunday (16May2021). Since then, she was feeling extremely tired and she hardly can keep her eyes open. She wanted to know if that was normal. Caller wanted to know how long can she expect her adverse event to occur. Response received as Responded per attached document; Referred to HCP. The caller has been feeling extremely tired and has been sleeping all day. The caller slept all day yesterday and today she already had two naps since she got up. How long will this normally last. How long has this lasted for other people. Other products, patient history and investigation assessment was not provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Experienced headache/migraines, lost 6 lbs in about 2 week, feels like he cannot control body temperature (hot/cold). Lasted about 3 weeks.
COVID-19 (from the first dose) and re-infection of COVID-19 after second dose/ diagnosed covid again on 03Feb2022; COVID-19 (from the first dose) and re-infection of COVID-19 after second dose/ diagnosed covid again on 03Feb2022; This is a spontaneous report received from a contactable reporter (Other HCP) for a Pfizer sponsored program (003110). The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administration date 01Dec2021 (Batch/Lot number: unknown) as dose 2, single and administration date Jun2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "CHF" (unspecified if ongoing); "PAH" (unspecified if ongoing); "DM2" (unspecified if ongoing); "CKD stage 3" (unspecified if ongoing); "non - smoker" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Feb2022, outcome "unknown" and all described as "COVID-19 (from the first dose) and re-infection of COVID-19 after second dose/ diagnosed covid again on 03Feb2022". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Feb2022) diagnosed covid. Clinical course: She got her first dose in Jun2021. Diagnosed covid the day she was supposed to get second dose 23Aug2021. Got monoclonial antibiodies. Received 2nd dose 01Dec2021. Diagnosed covid again 03Feb2022. Had CHF, PAH, DM2, CKD stage 3. 62 year old non - smoker, female. Maybe info could help with studies. The patient could not get booster until Jun2022. Patient was a retired nurse and keep a mask on in public and wash her hands and most of the time she wear gloves. Follow safety protocols.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.,Linked Report(s) : US-PFIZER INC-202200218630 same reporter, patient, product and event; different dose
Dizzy falling stumbling as to crawl across floor to let dogs out so I didn?t fall. Some nausea.
Patient came in on 7/27/09 c/o soreness left arm, neck and back. She said swelling, muscle soreness, fatigue, low grade fever, no energy. I looked and compared her left to right arm, deltoid tender to touch. Very slight erythema, and some slight limb swelling noted. Patient said she would go to her physician, and call me, 7/28/09. I called 9:45 somewhat better resolving 8/6/09 resolved but wanted me to report.
Left arm large reddish swelling (it started just yesterday  9th day after vaccine administration)
Information has been received from a office manager concerning a 4 year old male patient with no known drug reaction or allergies or pertinent medical history who on 02-MAR-2010 was intramuscularly vaccinated in the right arm with the first dose of VARIVAX (Merck) (Lot#665201/1294Y) 0.5 mL. Concomitant vaccination included MMR II, IPOL, and DTP + IPV. The office manager reporter that on 03-MAR-2010, the patient experienced redness, heat, rash and a very large swelling at the injection site which was the size of the bottom of a large pineapple juice can. On 05-MAR-2010 the patient was seen in the physician office. The patient was treated with BENADRYL. At the time of the report the patient had not recovered. It was noted that the office manager requested a lot check. A lot check has been initiated. Follow up information has been received from a medical assistant who reported that the patient who on 02-MAR-2010 was vaccinated with a dose of VARIVAX (Merck) (Lot #665201/1294Y). The patient was concomitant vaccinated with MMR II (Lot#663796/0423Y) in the left leg, IPOL (Lot#D0413-2) and (INFANRIX) (Lot#AC14B086AB). On an unspecified date, that patient had recovered. It was noted that the patient had a follow-up appointment with the physician on 12-MAR-2010. Additional information is not expected. This is one of several cases reported by the same source.
The patient was vaccinated with improperly stored Rotateq; No adverse event; This spontaneous report was received from a other health care professional referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were not reported.   On 23-FEB-2022, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (Lot# 1742462 and expiration date 19-SEP-2022) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a temperature excursion 49 degree Celsius for 72 hours. No previous temperature excursion. No additional adverse event reported, no further information provided.
Patient reported feeling fine (except for arm soreness as expected) until after went to bed for the night.  Woke up at 1130pm with rapid heartrate, severe headache, restlessness, could not rest, and body feeling very heavy. Took Tylenol and water and tried to lie down to rest.  Rapid heartbeat seemed to diminish by 7am, and headache lessened but still present.  Re-dosed with Tylenol again and continued to drink water to rehydrate and try to rest body.
Menactra was give prior to age 11 yrs. Experienced no problem. Misadmistration
Exp high pitched crying for approx 3 hrs 9SEP91 p/vax recvd; sx reported 18NOV91 when in for next immun;
This case was reported by a consumer (patient) and described the occurrence of arm pain at injection site in a 61-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medications included High blood pressure pill, Vitamin, Biotin and TYLENOL. On 14 October 2013 at 18:40 the subject received 1st dose of BOOSTRIX (unknown details, left arm) and experienced expired vaccine used. The BOOSTRIX expired on 14 October 2013. On the morning of 15 October 2013, 1 day after vaccination with BOOSTRIX, the subject experienced arm pain at injection site, muscle tightness under injection site, and injection site muscle reaction (described as "muscle stiffness and weakness" at the injection site). Within months of vaccination with BOOSTRIX, the subject experienced injection site reaction (difficulty in moving arm). Per the consumer, "this reaction has worsened in time." The consumer reported that she "has had left arm pain which involves muscle stiffness, muscle tightness, and muscle weakness." She also described "it as being unable to reach over her head to turn off the alarm clock in the morning." At the time of reporting, it was the consumer's opinion that the events were disabling. The consumer sought medical attention from the doctor's office. At the time of reporting the events were worse.
Shingles; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a health care provider for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
Patient experienced shaking for 3 hours following vaccination and nausea for 24 hours following vaccination.
Had normal side effects (pain in the arm, tired, joint pain, muscle soreness, chills, headache). The more adverse symptoms occurred later in the evening the same day -- rapid heart beat, hard to breathe, diarrhea, nausea. Extreme exhaustion for ~24-48 hours after the adverse event evening symptoms. Also experienced blurry vision for more than a few days after receiving the vaccine.
Feeling hot; like 4 days my arm hurt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling hot in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 2 days after receiving Shingles vaccine, the patient experienced feeling hot (Verbatim: Feeling hot) and pain in arm (Verbatim: like 4 days my arm hurt). The outcome of the feeling hot was unknown and the outcome of the pain in arm was resolved (duration 4 days).  It was unknown if the reporter considered the feeling hot and pain in arm to be related to Shingles vaccine.  It was unknown if the company considered the feeling hot and pain in arm to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 08-APR-2023 This case was reported by the patient via interactive digital media.  The reporter stated that the he/she had it for the first time and he/she would not have had it again. He/She had spent the second day feeling hot and like 4 days his/her arm hurt it is another le he/she recommend it. Follow-up would not possible, as no contact, details were available.
Patient reported initial "tingling" in injection arm which improved a few minutes post immunization. Sensation seemed to resolve. Husband reported 10/24/18 that patient experienced "tingling" and "dead arm" in other extremities. Follow up with patient 10/27/18 patient reports an "easement" of symptoms for a period but relief gone and "fatigue", "dead arm/leg" resumed. 10/28/18 - patient has been advised to contact her PCP and Intermed of this VAERS report with suspicion of GBS like symptoms. Husband contacted Intermed and advised that there was no concern. The contact was made before weekend 10/27/18 - I am advising patient to be reevaluated.
9 1/2 x 10 cm area of blanching, pink area left thigh, increased warmth.  Circumference of thigh 3 cm greater than right thigh.  Able to walk okay.
mom states pt had react ot vax 23JUL93 in rt thigh mom states pt had reaction to vax; shortly p/shot given was a silver dollar size induration w/redness around that for 48 hrs; low grade temp;
Small lump at area of injection, hot spot at area of injection, rash from site of injection to underside of arm, approximately the length of "two eggs".
This case was reported by a pharmacist via call center representative and described the occurrence of hives in a female patient who received SHINGRIX (batch number ZY3X4, expiry date 28th April 2020) for prophylaxis. On 22nd April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, 2 days after receiving SHINGRIX, the patient experienced hives. On an unknown date, the outcome of the hives was recovered/resolved. It was unknown if the reporter considered the hives to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced hives 48 hours after getting SHINGRIX.
This spontaneous report as received from a nurse practitioner refers to an eight patients of unknown age and gender. On 29-NOV-2016, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # M026306, expiry date 30-APR-2018) (dose and route were not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1612USA014070: US-009507513-1612USA014071: US-009507513-1612USA014072.
Patient developed angioedema of right face including lip and eye swelling on post vaccine day 4 requiring emergency treatment in the ED with steroids. The patient has no history of angioedema and etiology is unclear although within several days of booster prompting report. The angioedema appeared to be refractory to antihistamines while the steroid decreased lip swelling. Eye swelling remained for 4 days until self-resolution. Patient evaluated in allergy clinic with laboratory results pending for further angioedema workup.